Back to today’s briefing

Story perspectives

UCLA's MethylScan Blood Test Detects Cancers with 98% Accuracy

4/7/2026

46 11 Full Breakdown

Summary

Story summary

UCLA researchers developed MethylScan, a cost-effective blood test that analyzes cell-free DNA to detect multiple cancers and liver diseases.
MethylScan showed 98% specificity in studies with more than 1,000 participants and detected about 63% of cancers, including 55% of early-stage cases.
It detected nearly 80% of liver cancer cases and distinguished liver conditions with 85% accuracy, using DNA methylation patterns to reveal organ health.

1 of 1

Story summary

UCLA researchers developed MethylScan, a cost-effective blood test that analyzes cell-free DNA to detect multiple cancers and liver diseases.
MethylScan showed 98% specificity in studies with more than 1,000 participants and detected about 63% of cancers, including 55% of early-stage cases.
It detected nearly 80% of liver cancer cases and distinguished liver conditions with 85% accuracy, using DNA methylation patterns to reveal organ health.